Publications

  1. Adeli A, Savica R, Lowe VJ, Vemuri P, Knopman DS, Dejesus-Hernandez M, Rademakers R, Fields JA, Crum BA, Jack CR, Petersen RC, Boeve BF. The GGGGCC repeat expansion in C9ORF72 in a case with discordant clinical and FDG-PET findings: PET trumps syndrome. Neurocase. 2014; 20(1):110-20. Epub 2012 Nov 30.
    View PubMed
  2. Chopra A, Abulseoud OA, Sampson S, Lee KH, Klassen BT, Fields JA, Matsumoto JY, Adams AC, Stoppel CJ, Geske JR, Frye MA. Mood Stability in Parkinson Disease Following Deep Brain Stimulation: A 6-Month Prospective Follow-up Study. Psychosomatics. 2013 Dec 19.
    View PubMed
  3. McDade EM, Boeve BF, Fields JA, Kumar N, Rademakers R, Baker MC, Knopman BD, Petersen RC, Jack CR Jr, Kantarci K. MRS in early and presymptomatic carriers of a novel octapeptide repeat insertion in the prion protein gene. J Neuroimaging. 2013 Jul; 23(3):409-13. Epub 2012 May 21.
    View PubMed
  4. Van Gerpen JA, Lucas JA, Fields JA. Postsurgical behavioral changes. Milestones in Drug Therapy. 2013; 24:91-117.
  5. Chopra A, Tye SJ, Lee KH, Sampson S, Matsumoto J, Adams A, Klassen B, Stead M, Fields JA, Frye MA. Underlying neurobiology and clinical correlates of mania status after subthalamic nucleus deep brain stimulation in Parkinson's disease: a review of the literature. J Neuropsychiatry Clin Neurosci. 2012 Winter; 24(1):102-10.
    View PubMed
  6. Savica R, Adeli A, Vemuri P, Knopman DS, Dejesus-Hernandez M, Rademakers R, Fields JA, Whitwell J, Jack CR, Lowe V, Petersen RC, Boeve BF. Characterization of a family with c9FTD/ALS associated with the GGGGCC repeat expansion in C9ORF72. Arch Neurol. 2012 Sep; 69(9):1164-9.
    View PubMed
  7. McDade E, Boeve BF, Burrus TM, Boot BP, Kantarci K, Fields J, Lowe VJ, Peller P, Knopman D, Baker M, Finch N, Rademakers R, Petersen R. Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulin. Neurology. 2012 Apr 17; 78(16):1245-9. Epub 2012 Apr 04.
    View PubMed
  8. Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, Pedraza O, Vemuri P, Jones D, Lowe V, Murray ME, Dickson DW, Josephs KA, Rush BK, Machulda MM, Fields JA, Ferman TJ, Baker M, Rutherford NJ, Adamson J, Wszolek ZK, Adeli A, Savica R, Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain. 2012 Mar; 135(Pt 3):765-83.
    View PubMed
  9. Fields JA, Ferman TJ, Boeve BF, Smith GE. Neuropsychological assessment of patients with dementing illness. Nat Rev Neurol. 2011 Dec; 7(12):677-87. Epub 2011 Nov 01.
    View PubMed
  10. Kumar N, Boeve BF, Boot BP, Orr CF, Duffy J, Woodruff BK, Nair AK, Ellison J, Kuntz K, Kantarci K, Jack CR Jr, Westmoreland BF, Fields JA, Baker M, Rademakers R, Parisi JE, Dickson DW. Clinical characterization of a kindred with a novel 12-octapeptide repeat insertion in the prion protein gene. Arch Neurol. 2011 Sep; 68(9):1165-70.
    View PubMed
  11. Fields JA, Machulda M, Aakre J, Ivnik RJ, Boeve BF, Knopman DS, Petersen RC, Smith GE. Utility of the DRS for predicting problems in day-to-day functioning. Clin Neuropsychol. 2010 Oct; 24(7):1167-80.
    View PubMed
  12. Weiner MF, de la Plata CM, Fields JA, Womack KB, Rosenberg RN, Gong Y-H, Qu B-X, Diaz-Arrastia R, Hynan LS. Brain MRI, apolipoprotein E genotype, and plasma homocysteine in American Indian Alzheimer disease patients and Indian controls. Curr Alzheimer Res. 2009 Feb; 6(1):52-8.
  13. Weiner M, Fields J, Hynan L, Cullum CM. Annualized functional change in Alzheimer's disease participants and normal controls. Clin Neuropsychol. 2008 Sep; 22(5):801-6. Epub 2008 Mar 03.
    View PubMed
  14. Weiner MF, Rosenberg RN, Womack KB, Svetlik DA, Fuller C, Fields J, Hynan LS. Atherosclerosis risk factors in American Indians with Alzheimer disease: preliminary findings. Alzheimer Dis Assoc Disord. 2008 Jul-Sep; 22(3):245-8.
    View PubMed
  15. Woods SP, Scott JC, Fields JA, Poquette A, Troster AI. Executive dysfunction and neuropsychiatric symptoms predict lower health status in essential tremor. Cogn Behav Neurol. 2008 Mar; 21(1):28-33.
    View PubMed
  16. Borson S, Scanlan J, Friedman S, Zuhr E, Fields J, Aylward E, Mahurin R, Richards T, Anzai Y, Yukawa M, Yeh S. Modeling the impact of COPD on the brain. Int J Chron Obstruct Pulmon Dis. 2008; 3(3):429-34.
    View PubMed
  17. Allen G, Barnard H, McColl R, Hester AL, Fields JA, Weiner MF, Ringe WK, Lipton AM, Brooker M, McDonald E, Rubin CD, Cullum CM. Reduced hippocampal functional connectivity in Alzheimer disease. Arch Neurol. 2007 Oct; 64(10):1482-7.
    View PubMed
  18. Troster AI, Fields JA, Paolo AM, Koller WC. Absence of the apolipoprotein E epsilon4 allele is associated with working memory impairment in Parkinson's disease. J Neurol Sci. 2006 Oct 25; 248(1-2):62-7.
    View PubMed
  19. Unutzer J, Tang L, Oishi S, Katon W, Williams JW Jr, Hunkeler E, Hendrie H, Lin EH, Levine S, Grypma L, Steffens DC, Fields J, Langston C, IMPACT Investigators. Reducing suicidal ideation in depressed older primary care patients. J Am Geriatr Soc. 2006 Oct; 54(10):1550-6.
    View PubMed
  20. Troster AI, Pahwa R, Fields JA, Tanner CM, Lyons KE. Quality of life in Essential Tremor Questionnaire (QUEST): development and initial validation. Parkinsonism Relat Disord. 2005 Sep; 11(6):367-73.
    View PubMed
  21. Piatt AL, Fields JA, Paolo AM, Troster AI. Action verbal fluency normative data for the elderly. Brain Lang. 2004 Jun; 89(3):580-3.
    View PubMed
  22. Woods SP, Fields JA, Lyons KE, Pahwa R, Troster AI. Pulse width is associated with cognitive decline after thalamic stimulation for essential tremor. Parkinsonism Relat Disord. 2003 Jun; 9(5):295-300.
    View PubMed
  23. Croyle KL, Tröster AI, Fields JA, Straits-Tröster KA, Lyons KE, Pahwa R. Presurgical coping, depression, and quality of life in persons with Parkinson's disease. J Clin Psychol Med Settings. 2003 Jun; 10(2):101-7.
  24. Fields JA, Troster AI, Woods SP, Higginson CI, Wilkinson SB, Lyons KE, Koller WC, Pahwa R. Neuropsychological and quality of life outcomes 12 months after unilateral thalamic stimulation for essential tremor. J Neurol Neurosurg Psychiatry. 2003 Mar; 74(3):305-11.
    View PubMed
  25. Troster AI, Fields JA, Wilkinson S, Pahwa R, Koller WC, Lyons KE. Effect of motor improvement on quality of life following subthalamic stimulation is mediated by changes in depressive symptomatology. Stereotact Funct Neurosurg. 2003; 80(1-4):43-7.
    View PubMed
  26. Troster AI, Woods SP, Fields JA. Verbal fluency declines after pallidotomy: an interaction between task and lesion laterality. Appl Neuropsychol. 2003; 10(2):69-75.
    View PubMed
  27. Norman S, Troster AI, Fields JA, Brooks R. Effects of depression and Parkinson's disease on cognitive functioning. J Neuropsychiatry Clin Neurosci. 2002 Winter; 14(1):31-6.
    View PubMed
  28. Troster AI, Woods SP, Fields JA, Hanisch C, Beatty WW. Declines in switching underlie verbal fluency changes after unilateral pallidal surgery in Parkinson's disease. Brain Cogn. 2002 Nov; 50(2):207-17.
    View PubMed
  29. Woods SP, Fields JA, Troster AI. Neuropsychological sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a critical review. Neuropsychol Rev. 2002 Jun; 12(2):111-26.
    View PubMed
  30. Troster AI, Woods SP, Fields JA, Lyons KE, Pahwa R, Higginson CI, Koller WC. Neuropsychological deficits in essential tremor: an expression of cerebello-thalamo-cortical pathophysiology? Eur J Neurol. 2002 Mar; 9(2):143-51.
    View PubMed
  31. Woods SP, Fields JA, Lyons KE, Koller WC, Wilkinson SB, Pahwa R, Troster AI. Neuropsychological and quality of life changes following unilateral thalamic deep brain stimulation in Parkinson's disease: a one-year follow-up. Acta Neurochir (Wien). 2001 Dec; 143(12):1273-7; discussion 1278.
    View PubMed
  32. Higginson CI, Fields JA, Koller WC, Tröster AI. Questionnaire assessment potentially overestimates anxiety in Parkinson's disease. J Clin Psychol Med Settings. 2001 Jun; 8(2):95-9.
  33. Higginson CI, Fields JA, Troster AI. Which symptoms of anxiety diminish after surgical interventions for Parkinson disease? Neuropsychiatry Neuropsychol Behav Neurol. 2001 Apr-Jun; 14(2):117-21.
    View PubMed
  34. Straits-Troster K, Fields JA, Wilkinson SB, Pahwa R, Lyons KE, Koller WC, Troster AI. Health-related quality of life in Parkinson's disease after pallidotomy and deep brain stimulation. Brain Cogn. 2000 Apr; 42(3):399-416.
    View PubMed
  35. Fields JA, Troster AI. Cognitive outcomes after deep brain stimulation for Parkinson's disease: a review of initial studies and recommendations for future research. Brain Cogn. 2000 Mar; 42(2):268-93.
    View PubMed
  36. Piatt AL, Fields JA, Paolo AM, Troster AI. Action (verb naming) fluency as an executive function measure: convergent and divergent evidence of validity. Neuropsychologia. 1999 Dec; 37(13):1499-503.
    View PubMed
  37. Troster AI, Fields JA, Pahwa R, Wilkinson SB, Strait-Troster KA, Lyons K, Kieltyka J, Koller WC. Neuropsychological and quality of life outcome after thalamic stimulation for essential tremor. Neurology. 1999 Nov 10; 53(8):1774-80.
    View PubMed
  38. Fields JA, Troster AI, Wilkinson SB, Pahwa R, Koller WC. Cognitive outcome following staged bilateral pallidal stimulation for the treatment of Parkinson's disease. Clin Neurol Neurosurg. 1999 Sep; 101(3):182-8.
    View PubMed
  39. Piatt AL, Fields JA, Paolo AM, Koller WC, Troster AI. Lexical, semantic, and action verbal fluency in Parkinson's disease with and without dementia. J Clin Exp Neuropsychol. 1999 Aug; 21(4):435-43.
    View PubMed
  40. Troster AI, Wilkinson SB, Fields JA, Miyawaki K, Koller WC. Chronic electrical stimulation of the left ventrointermediate (Vim) thalamic nucleus for the treatment of pharmacotherapy-resistant Parkinson's disease: a differential impact on access to semantic and episodic memory? Brain Cogn. 1998 Nov; 38(2):125-49.
    View PubMed
  41. Testa JA, Tröster AI, Fields JA, Gleason AC, Salmon DP, Beatty WW. Semantic fluency performance of patients with cortical and subcortical neurodegenerative diseases. Aging Neuropsychol Cogn. 1998 Sep; 5(3):203-14.
  42. Troster AI, Fields JA, Testa JA, Paul RH, Blanco CR, Hames KA, Salmon DP, Beatty WW. Cortical and subcortical influences on clustering and switching in the performance of verbal fluency tasks. Neuropsychologia. 1998 Apr; 36(4):295-304.
    View PubMed
  43. Troster AI, Fields JA, Wilkinson SB, Pahwa R, Miyawaki E, Lyons KE, Koller WC. Unilateral pallidal stimulation for Parkinson's disease: neurobehavioral functioning before and 3 months after electrode implantation. Neurology. 1997 Oct; 49(4):1078-83.
    View PubMed
  44. Tröster AI, Fields JA, Wilkinson SB, Busenbark K, Miyawaki E, Overman J, Pahwa R, Koller WC. Neuropsychological functioning before and after unilateral thalamic stimulating electrode implantation in Parkinson's disease. Neurosurgical FOCUS. 1997; 2(3):E11.
  45. Tröster AI, Osorio I, Fields JA, Lai CW, Eckard DA, Preston DF, Whitaker HA. Transient alexia (letter-by-letter reading) after single photon emission computed tomography-verified selective left posterior cerebral artery sodium amytal injection. Neuropsychiatry Neuropsychology and Behavioral Neurology. 1996 Jul; 9(3):209-17.
  46. Tröster AI, Fields JA, Paolo AM, Koller WC. Performance of individuals with Parkinson's disease on the Vocabulary and Information subtests of the WAIS-R as a Neuropsychological Instrument. J Clin Geropsychology. 1996; 2:215-23.
  47. Tröster AI, Stalp L, Paolo AM, Fields JA, Koller WC. Neuropsychological impairment in Parkinson's disease with and without depression. Parkinson/Alzheimer Digest. 1996; 5:5-7.
  48. Troster AI, Stalp LD, Paolo AM, Fields JA, Koller WC. Neuropsychological impairment in Parkinson's disease with and without depression. Arch Neurol. 1995 Dec; 52(12):1164-9.
    View PubMed
  49. Tröster AI, Fields JA. Frontal cognitive function and memory in Parkinson's disease: Toward a distinction between prospective and declarative memory impairments. Alzheimer Dis Assoc Disord. 1995; 8(2):59-74.